Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Alpha-9 Oncology USA Inc.
Centre Oscar Lambret
Emory University
MonTa Biosciences ApS
Replimune Inc.
Mayo Clinic
M.D. Anderson Cancer Center
Fusion Pharmaceuticals Inc.
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
Massachusetts Eye and Ear Infirmary
Modulation Therapeutics, Inc.
TriSalus Life Sciences, Inc.
Novelty Nobility, Inc.
Vastra Gotaland Region
Vastra Gotaland Region
Emory University
Memorial Sloan Kettering Cancer Center
Vastra Gotaland Region